URI professor earns 2026 Sillerman First Book Prize for African Poets...
RACHEL AFIA ANSONG, an assistant professor of Africana studies at the University of Rhode Island, was recently presented the 2026 Sillerman First Book Prize...
Five Questions With: Julie Abilheira
Julie Abilheira | President, Morton Hospital and Saint Anne’s Hospital
1. What skills and experience from your most recent role as Brown University Health’s...
Five Questions With: Lisa Ardente
Lisa Ardente is a broker associate at Compass Inc., based in Providence, who has worked in Rhode Island real estate for more than a...
Five Questions With: Laura R. Stroud
While research and educational institutes across the country struggle to access federal funding, The Miriam Hospital was awarded $11.1 million in August from the...
Five Questions With: Suzanne Silva
Suzanne Silva has served as the CEO of the Greater Providence Board of Realtors, Northern Rhode Island Board of Realtors and the Greater Providence...
Five Questions With: James B. Connell
Age-Friendly Rhode Island, a Providence-based nonprofit advocating for inclusive communities for older adults, reports the percentage of Rhode Islanders 65 and older will grow...
Five Questions With: Bob Cappadona
Bob Cappadona | CEO and president, Veolia North America’s Hazardous Waste division
1. Environmental solutions company Veolia, based in France with a North American...
Davies student earns national gold medal in first aid and CPR...
ARIANNE CHARLES, a North Providence student at William M. Davies Jr. Career and Technical High School in Lincoln, won the national gold medal in...
Five Questions With: Christina Paolino
Christina Paolino recently joined Paolino Properties LLC, the Providence-based real estate development and management firm founded by her great-grandfather in 1900 and led by...
Five Questions With: Pam Stetkiewicz
After operating in stealth for its first year, Lyora Therapeutics publicly launched in July, announcing Pam Stetkiewicz as the Providence-based biotech company’s CEO.
With $2.5 million in pre-seed funding, Lyora develops medications for those living with inherited...



















